Reviva Pharmaceuticals Holdings, Inc. Common Stock
Symbol: RVPH (NASDAQ)
Company Description:
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
- Today's Open: $0.438
- Today's High: $0.442
- Today's Low: $0.434
- Today's Volume: 352.75K
- Yesterday Close: $0.4679
- Yesterday High: $0.4779
- Yesterday Low: $0.4521
- Yesterday Volume: 1.29M
- Last Min Volume: 102
- Last Min High: $0.439
- Last Min Low: $0.439
- Last Min VWAP: $0.439
- Name: Reviva Pharmaceuticals Holdings, Inc. Common Stock
- Website: https://www.revivapharma.com
- Listed Date: 2020-12-15
- Location: CUPERTINO, CA
- Market Status: Active
- CIK Number: 0001742927
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $29.62M
- Round Lot: 100
- Outstanding Shares: 68.00M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-07-01 | SCHEDULE 13D/A | View |
| 2025-07-01 | SCHEDULE 13D/A | View |
| 2025-07-01 | SCHEDULE 13G | View |
| 2025-06-26 | 8-K | View |
| 2025-06-26 | 424B5 | View |
| 2025-06-25 | 424B5 | View |
| 2025-06-06 | 8-K | View |
| 2025-06-02 | 8-K | View |
| 2025-05-30 | 424B5 | View |
| 2025-05-30 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
| 2025-05-15 | 8-K | View |
| 2025-04-03 | S-8 | View |
| 2025-04-03 | 10-K | View |
| 2025-03-31 | NT 10-K | View |
| 2025-03-31 | 8-K | View |
| 2025-02-18 | 8-K | View |
| 2025-02-18 | 4 | View |
| 2025-02-18 | 4 | View |